Aduro BioTech

company

About

Aduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies.

  • 101 - 250

Details

Last Funding Type
Series D
Last Funding Money Raised
$51.40M
Industries
Biopharma,Biotechnology,Life Science
Founded date
Jan 1, 2000
Number Of Employee
101 - 250
Operating Status
Active

Aduro Biotech is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases.It was founded in 2000 and headquartered in Berkeley, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$51.40M
Aduro BioTech has raised a total of $51.40M in funding over 2 rounds. Their latest funding was raised on Jan 5, 2015 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 5, 2015 Series D $51.40M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Aduro BioTech is funded by 1 investors. Franklin Advisors are the most recent investors.
Investor Name Lead Investor Funding Round
Franklin Advisors Series D